WASHINGTON, Nov 9 (Reuters) - Thermage Inc., a wrinkle treatment medical company, on Thursday cut the expected price of its planned initial public offering to $8 to $9 per share from $11 to $13.
The company still intends to sell 6 million shares in the IPO, according to an amended offering document filed with the U.S. Securities and Exchange Commission. Merrill Lynch & Co., Thomas Weisel Partners LLC, Wachovia Securities, C. E. Unterberg Towbin, and Maxim Group LLC are underwriting the IPO. <<
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.